ERBB2 and breast cancer: These and similar results in the AR-positive, ER-positive, ErbB2 active cell line, BT474 (Supplementary Fig. 10), suggest that suppression of androgen signalling results in increased DNA damage and/or decreased repair in breast cancer cells that express AR, independent of ER and ErbB2 activity.